ManuMycin B

ManuMycin B Struktur
139023-58-8
CAS-Nr.
139023-58-8
Englisch Name:
ManuMycin B
Synonyma:
ManuMycin B;(2E,4R)-N-[(1S,5S,6R)-5-Hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4-dimethyl-2-octenamide;2-Octenamide, N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4-dimethyl-, (2E,4R)-
CBNumber:
CB92650613
Summenformel:
C28H34N2O7
Molgewicht:
510.58
MOL-Datei:
139023-58-8.mol

ManuMycin B Eigenschaften

Siedepunkt:
842.0±65.0 °C(Predicted)
Dichte
1.29±0.1 g/cm3(Predicted)
pka
3.80±0.30(Predicted)
Aggregatzustand
powder
Farbe
Yellow to brown

Sicherheit

ManuMycin B Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Manumycin B (cas# 139023-58-8) is a compound useful in organic synthesis.

ManuMycin B Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


ManuMycin B Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 19)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52927 58
Shanghai Tauto Biotech Co., Ltd. 021-51320588
tauto@tautobiotech.com China 3989 66
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9709 58
Lynnchem 86-(0)29-85992781 17792393971
info@lynnchem.com China 4587 58
Novachemistry 44-20819178-90 02081917890
info@novachemistry.com United Kingdom 4381 58

  • ManuMycin B
  • (2E,4R)-N-[(1S,5S,6R)-5-Hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4-dimethyl-2-octenamide
  • 2-Octenamide, N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4-dimethyl-, (2E,4R)-
  • 139023-58-8
Copyright 2019 © ChemicalBook. All rights reserved